EISAI CO., LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6,753 JPY | +2.71% |
|
-0.16% | -4.24% |
| May. 24 | BioArctic, Eisai's Azlheimer’s Disease Drug Wins Regulatory Nod in South Korea | MT |
| May. 16 | Eisai's Attributable Profit Falls 23.5% in Fiscal 2024 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 12.04B | ||||||
| 734B | ||||||
| 591B | ||||||
| 350B | ||||||
| 315B | ||||||
| 276B |
- Stock Market
- Equities
- 4523 Stock
- Charts Eisai Co., Ltd.
- Sector Chart
